NEA

New Enterprise Associates (NEA) is a prominent global venture capital firm established in 1977, dedicated to partnering with visionary founders to build impactful companies across the technology and healthcare sectors. With offices in key innovation hubs like Menlo Park, California, and New York City, NEA has a significant global presence, extending its reach to London, Timonium, and affiliate offices in major Asian cities such as Mumbai, Bangalore, Beijing, and Shanghai. The firm focuses on a full lifecycle investment strategy, engaging with companies from their nascent seed stages through to initial public offerings (IPOs) and beyond.

NEA’s core philosophy is rooted in a 'people-first' approach, fostering enduring partnerships and providing comprehensive operational support that extends far beyond mere capital injection. This commitment involves active collaboration, deep domain expertise, and a vast network of seasoned business leaders, technologists, and entrepreneurs who serve as venture partners, enriching the guidance offered to portfolio companies. The firm prides itself on its internal promotion culture, with general partners averaging 17 years of tenure, cultivating deep institutional knowledge and a consistent investment approach.

Over its nearly five-decade history, NEA has demonstrated a remarkable track record, having facilitated over 280 IPOs and more than 500 mergers and acquisitions, making it one of the largest and most established venture capital firms globally. The firm manages substantial assets, with over $28 billion in committed capital as of 2025, deploying these funds into innovative businesses that are poised to redefine their respective industries. Key achievements include backing transformative companies that have become household names, demonstrating NEA's consistent ability to identify and nurture market leaders.

Under the leadership of Executive Chairman and Chief Investment Officer Scott Sandell, and Co-CEOs Tony Florence and Mohamad Makhzoumi, NEA maintains a dual-track investment model, with dedicated practices for technology and healthcare. This structure allows for specialised expertise and collaborative decision-making, ensuring a thorough evaluation of opportunities at the intersection of these two critical sectors. The firm's investment thesis emphasises scalable, innovative business models that address expansive, rapidly growing markets, with a strategic focus on areas like enterprise software, AI, fintech, life sciences, and digital health.